On Invalid Date, Reneo Pharmaceuticals (NASDAQ: RPHM) reported Q4 2023 earnings per share (EPS) of -$0.71, up 29.09% year over year. Total Reneo Pharmaceuticals earnings for the quarter were -$23.55 million. In the same quarter last year, Reneo Pharmaceuticals's earnings per share (EPS) was -$0.55.
As of Q2 2024, Reneo Pharmaceuticals's earnings has grown year over year. Reneo Pharmaceuticals's earnings in the past year totalled -$77.39 million.
What is RPHM's earnings date?
Reneo Pharmaceuticals's earnings date is Invalid Date. Add RPHM to your watchlist to be reminded of RPHM's next earnings announcement.
What was RPHM's revenue last quarter?
On Invalid Date, Reneo Pharmaceuticals (NASDAQ: RPHM) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Reneo Pharmaceuticals's revenue was $0.00.
What was RPHM's revenue growth in the past year?
As of Q2 2024, Reneo Pharmaceuticals's revenue has grown null year over year. Reneo Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.